Senzime AB (SEZI)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Senzime AB (SEZI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013627
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Senzime AB (Senzime) is a medical device company that develops patient-oriented monitoring systems. The company’s product include TetraGraph monitor, CliniSenz analyzer, and Onzurf probe. Its TetraGraph monitor stimulates, measures, analyzes and displays muscle function in surgical patients receiving neuromuscular blocking agents. Senzime’s portfolio of technologies includes bedside systems that enable automated and continuous measurement of biological substances as glucose and lactate in the blood and tissue fluid and patient-system for peri-operative monitoring of the neuromuscular function in patients undergoing depth of anesthesia. The company’s products are used in the areas of medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. Senzime is headquartered in Uppsala, Sweden.

Senzime AB (SEZI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Senzime AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Senzime AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Senzime AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Senzime AB, Medical Devices Deals, 2011 to YTD 2017 8
Senzime AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Senzime AB, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Senzime Raises USD2.7 Million in Rights Offering of Shares 10
Senzime Raises USD1.15 Million in Private Placement of Shares 11
Senzime Raises USD2.8 Million in Rights Offering of Shares 12
Senzime to Raise USD1.9 Million in Rights Offering of Shares 13
Senzime Raises USD1 Million in Rights Offering of Common Shares 14
Senzime AB – Key Competitors 15
Senzime AB – Key Employees 16
Senzime AB – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Aug 31, 2017: Senzime’s Interim report January – June 2017 18
May 31, 2017: Senzime’s Interim report January – March 2017 19
Corporate Communications 21
Jun 07, 2016: Senzime strengthens management – hires new CFO and Director of Business Development 21
Other Significant Developments 22
Feb 07, 2017: Senzime launches new website 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Senzime AB, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Senzime AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Senzime AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Senzime AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Senzime AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Senzime AB, Medical Devices Deals, 2011 to YTD 2017 8
Senzime AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Senzime Raises USD2.7 Million in Rights Offering of Shares 10
Senzime Raises USD1.15 Million in Private Placement of Shares 11
Senzime Raises USD2.8 Million in Rights Offering of Shares 12
Senzime to Raise USD1.9 Million in Rights Offering of Shares 13
Senzime Raises USD1 Million in Rights Offering of Common Shares 14
Senzime AB, Key Competitors 15
Senzime AB, Key Employees 16
Senzime AB, Subsidiaries 17

★海外企業調査レポート[Senzime AB (SEZI)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fluor Corp (FLR)
    Fluor Corp (FLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Copperbelt Energy Corporation Plc (CEC):企業の財務・戦略的SWOT分析
    Copperbelt Energy Corporation Plc (CEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Thor Industries, Inc.:企業の戦略・SWOT・財務情報
    Thor Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Thor Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Oncgnostics GmbH-医療機器分野:企業M&A・提携分析
    Summary Oncgnostics GmbH (Oncgnostics) is an in-vitro diagnostic company that specializes in the development of in-vitro diagnostic tests for the therapeutics area of cancer. The company’s pipeline offers GynTect technology, a system based on the detection of epigenetic biomarkers, mainly in the met …
  • Harbour Centre Development Ltd:企業の戦略・SWOT・財務情報
    Harbour Centre Development Ltd - Strategy, SWOT and Corporate Finance Report Summary Harbour Centre Development Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Karyopharm Therapeutics Inc (KPTI):企業の財務・戦略的SWOT分析
    Karyopharm Therapeutics Inc (KPTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Emerson Electric Co (EMR):石油・ガス:M&Aディール及び事業提携情報
    Summary Emerson Electric Co. (Emerson) is a provider of infrastructure technologies and life cycle services for information and communication technology systems. The company offers hardware and software solutions for power, thermal and infrastructure management under the brands of Kop-Flex, jaure, a …
  • Building Energy SpA:石油・ガス:M&Aディール及び事業提携情報
    Summary Building Energy SpA (Building Energy) is a renewable energy company that operates and develops renewable energy projects such as biomass, hydro, wind and solar projects. The company provides operation and maintenance services such as real time performance monitoring, performance guarantee, p …
  • Guizhou Space Appliance Co., Ltd.
    Guizhou Space Appliance Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Guizhou Space Appliance Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Cypralis Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Cypralis Ltd (Cypralis), formerly Selcia Pharma Ltd is a drug developer that provides discovery and development of therapeutics targeting peptidyl-prolyl isomerases. The company spans its expertise in the development of medicines for degenerative diseases such as acute tissue injury, liver d …
  • PT PLN (Persero):発電所・企業SWOT分析
    PT PLN (Persero) – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Commonwealth Bank of Australia:戦略・SWOT・企業財務分析
    Commonwealth Bank of Australia - Strategy, SWOT and Corporate Finance Report Summary Commonwealth Bank of Australia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Lundin Petroleum AB (LUPE):石油・ガス:M&Aディール及び事業提携情報
    Summary Lundin Petroleum AB (Lundin Petroleum) is an independent oil and gas exploration and production company that acquires, explores, develops and produces oil and gas properties in Norway. The company identifies and matures exploration targets, drill exploration wells, appraise discoveries, and …
  • ERG SpA (ERG):電力:M&Aディール及び事業提携情報
    Summary ERG S.p.A. (ERG), a subsidiary of San Quirico S.P.A., is a diversified energy company. Through its subsidiaries, it conducts power generation through renewable and thermal sources. The company carries out the distribution and marketing of petroleum products and conducts refining activities. …
  • IMCO Industries Ltd.:企業の戦略・SWOT・財務情報
    IMCO Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary IMCO Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Mylan NV (MYL)-製薬・医療分野:企業M&A・提携分析
    Summary Mylan NV (Mylan) is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generics and branded medicines and consumer healthcare products. It offers pharmaceutical products in multiple forms across therapeutic categories such as respiratory and allergy, ca …
  • Travis Perkins plc:企業の戦略・SWOT・財務分析
    Travis Perkins plc - Strategy, SWOT and Corporate Finance Report Summary Travis Perkins plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Montefiore Medical Center-医療機器分野:企業M&A・提携分析
    Summary Montefiore Medical Center (MMC) is a healthcare service provider that offers clinical services. The center offers services such as allergy and immunology, orthopaedics, dentistry and oral surgery, dermatology, endocrinology, digestive and liver diseases, neurological surgery, otorhinolaryngo …
  • The Ultimate Software Group Inc (ULTI):企業の財務・戦略的SWOT分析
    The Ultimate Software Group Inc (ULTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • 01 Communique (ONE):企業の財務・戦略的SWOT分析
    Summary 01 Communique (Communique) is a technology company that develops and delivers integrated communication software and services. The company's products include I'm InTouch meeting, I'm InTouch, I'm OnCall and Communicate!. Communique I'm InTouch provides a secure and easy to use PC remote acces …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆